The IRA was a critical first step at systemically lowering the prices of prescription drugs for Americans.
What recommendations do you have for how and where to increase transparency throughout the prescription drug supply chain?
People care a whole lot about this matter of getting mugged at the pharmacy counter.
I am going to go out and have all these town hall meetings, and I am going to hold that up.
I am leading a bill with Senator Grassley, the Pharmacy Benefit Manager Transparency Act, which would crack down on PBM's opaque rebate prac...
I am working on a bill with Senator Grassley, the Pharmacy Benefit Manager Transparency Act, which would shine a light on bad PBM practices.
Every drug should have a price that is available for all to see and creates equity.
The average price that PBMs charge Medicare Part D plans for the exact same drug is over $3,000.
The Pharmacy Benefit Manager Transparency Act of 2023 would make material improvements to the transparency of the U.S. health-care system.
That means looking at pharmacy benefit manager practices with a thorough eye and taking any legislative steps necessary to ensure taxpayers ...
In my view, that's a clear example of the perverse incentives PBMs have created that leave so many Americans fed up and outraged at the heal...
Our bipartisan efforts on organ transplants--thank you very much, Senator Grassley--have really paid off.
The problem is that the person negotiating on behalf of the patient should not be getting paid by the other side.
It undermines the negotiation entirely.
That is why I previously cosponsored something called Creating Transparency to Have Drug Rebates Unlocked.
